Retractable syringes maker Unilife Corporation (UNIS) reported that it has developed the AutoInfusor subcutaneous (under the skin) infusion systems. It is the world’s first and only automated subcutaneous infusion system geared for patient self-administration of drugs with dose volumes between 3mL (milliliter) and 10mL.
The single-use, wearable, AutoInfusors drug delivery systems are intended for simple and convenient use by patients. These breakthrough infusion systems can be customized to meet the specific requirement of the drug and its target patient.
Once a patient attaches the AutoInfusors system to the injection site and presses the activation button, the device commences the delivery of the drug into the subcutaneous tissue. The patient can continue his/her normal activities during the dose delivery period. The audio-visual indicators notify the patient about the completion of full dose delivery, following which, the device can be removed from the body and conveniently disposed.
Currently, a number of drugs, developed by pharma companies, feature complex formulation and require large volumes of doses. The traditional patch pumps for drug delivery are mostly unsuitable for delivering these medications. So far, pharma companies had lack of access to a single-use subcutaneous infusion system that allow patients to conveniently self-administer doses higher than 3mL.
Unilife has designed the AutoInfusor systems to address the unmet needs of pharma and biotechnology companies for drugs that have complex formulations and require large dose volumes. The company noted that the product is now available for supply to pharma companies for human clinical studies in both pre-filled and fill-at-time-of-use formats.
Unilife develops and markets advanced drug delivery systems. It collaborates with biotech and pharmaceutical companies and explores new devices that could be used with their drugs. The company has developed a wide array of its own injectable drug delivery products, including retractable syringes.
Unilife markets its prefilled syringes to pharmaceutical manufacturers, suppliers of medical products to healthcare facilities and patients who self-administer prescription drugs. Its patented syringes provide integrated safety, which is designed to protect patients from needle-stick injuries. Unilife competes with Becton, Dickinson and Company (BDX) among others.
